Clinical Trials · NCT04184947
Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University of Padova
- Enrollment
- 10,000
- Start date
- Mar 2014
- Locations
- 1 site, Italy
- Primary endpoint
- 3 point major adverse cardiovascular events (4P-MACE)